Suraksha Diagnostic IPO Day 2 Live Updates: Issue booked 11% so far. Check GMP, subscription status, more

Suraksha Diagnostic IPO Day 2 Live Updates: The initial public offering (IPO) of Suraksha Diagnostic Ltd was 11% subscribed on the first day of the share sale, which took place on Friday. The portion allocated to Retail Individual Investors (RIIs) was 20% subscribed, while non-institutional investors received a subscription of 4%, according to data from the Bombay Stock Exchange (BSE).

On Thursday, Suraksha Diagnostic Ltd, an integrated diagnostic chain, announced that it has raised ₹254 crore from anchor investors.

The initial share sale, valued at ₹846 crore, will close on December 3. Shares are priced between ₹420 and ₹441 each.

The Kolkata-based company’s IPO includes an Offer for Sale (OFS) of 19,189,330 equity shares, worth ₹846.25 crore at the upper end of the price range. This sale will be conducted by promoters and investor shareholders, with no new shares being issued.

Suraksha Diagnostic provides a comprehensive solution for pathology and radiology testing, as well as medical consultation services. This is facilitated through a broad operational network that includes a central reference laboratory, eight satellite laboratories, and 194 customer touchpoints. These touchpoints consist of 48 diagnostic centers and 146 sample collection centers, primarily operated as franchises, across West Bengal, Bihar, Assam, and Meghalaya, as of March 31, 2024.